DCLK1 and head and neck cancer: Our results demonstrate that silencing of DCLK1, through either pharmacologic inhibitor or siRNA, significantly inhibited key neoplastic characteristics of the head and neck cancer cell lines, such as proliferation, migration, and invasion, whereas overexpression of DCLK1 in normal keratinocytes induced cell proliferation and survival, and was associated with elevated expression of stemness markers.